Please check your internet connection and try again.
# Lorazepam (Benzodiazepine)
## Overview
Lorazepam is a benzodiazepine with anxiolytic, sedative, hypnotic, amnestic, and anticonvulsant properties. It acts by enhancing the inhibitory effects of gamma-aminobutyric acid (GABA) in the central nervous system.
## Primary Indications
* Anxiety disorders
* Insomnia (short-term treatment)
* Status epilepticus (acute treatment)
* Premedication for surgical procedures
* Sedation for procedures
## Adult Dosing
* **Anxiety:** 0.5 mg to 2 mg orally every 6 to 8 hours as needed. Doses can be increased gradually. Maximum recommended daily dose is typically 10 mg, but higher doses may be used under close medical supervision.
* **Insomnia:** 1 mg to 2 mg orally at bedtime.
* **Status Epilepticus:** 4 mg intravenously or intramuscularly. A repeat dose of 4 mg may be administered after 10 to 15 minutes if seizures persist.
* **Premedication:** 2 mg to 4 mg orally or intravenously 2 hours before surgery or 2 hours before induction of anesthesia.
* **Procedure Sedation:** 0.044 mg/kg intravenously, not to exceed 4 mg, given 2 minutes before the procedure.
## Pediatric Dosing
Dosing in pediatric patients is highly variable and should be based on weight and clinical indication. There is limited established dosing for routine outpatient use.
* **Status Epilepticus:** 0.1 mg/kg intravenously or intramuscularly, not to exceed 4 mg per dose. Repeat every 5 to 10 minutes if necessary. Maximum total dose of 0.2 mg/kg or 10 mg.
* **Sedation:** Dosing for procedural sedation is not well-established and requires careful titration and monitoring.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; dose reduction may be necessary.
* **Renal Impairment:** No specific dose adjustment, but use with caution.
* **Elderly:** Start with lower doses (e.g., 0.5 mg orally twice daily) due to increased sensitivity to CNS effects.
## Contraindications
* Hypersensitivity to lorazepam or other benzodiazepines.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency (though use in hepatic impairment may be considered cautiously with dose adjustment).
* Sleep apnea.
## Adverse Effects
Common adverse effects include drowsiness, dizziness, fatigue, ataxia, and cognitive impairment. Less common effects include confusion, depression, dysarthria, blurred vision, and paradoxical reactions (e.g., excitement, aggression). Respiratory depression is a risk, especially with IV administration or in combination with other CNS depressants.
## Key Drug Interactions
* **CNS Depressants (opioids, alcohol, other sedatives/hypnotics):** Increased risk of profound sedation, respiratory depression, coma, and death.
* **Theophylline/Aminophylline:** May reduce the sedative effects of lorazepam.
* **Valproic acid:** May increase lorazepam levels.
## Monitoring
* Respiratory rate, oxygen saturation, and level of consciousness, especially with parenteral administration or in high-risk patients.
* Signs of dependence and withdrawal with prolonged use.
* Cognitive function and functional status.
## Clinical Pearls
* Oral lorazepam has a slower onset of action than IV/IM.
* Intravenous lorazepam should be administered slowly to avoid hypotension and respiratory depression.
* Avoid abrupt discontinuation after prolonged use to prevent withdrawal symptoms. Tapering of the dose is recommended.
* Lorazepam is generally not the first-line agent for long-term management of anxiety disorders due to risks of dependence and tolerance.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and institutional protocols before making clinical decisions.
